Stock Events

Stock Events

Neurogene 

€17.2
0
-€0.2-1.15% Friday 19:32

Statistics

Day High
18
Day Low
16.9
52W High
29.78
52W Low
6.55
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

8MayExpected
Next
-1.11
-0.78
-0.45
-0.11
Expected EPS
-1.1122951008000002
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow UU8.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Show more...
CEO
Dr. Rachel L. McMinn Ph.D.
Employees
107
Country
United States
ISIN
US64135M1053

Listings

STU
DE
UU8.STU
F
DE
UU8.F
XNAS
US
NGNE
BOATS
BOATS
NGNE.BOATS

0 Comments

Share your thoughts

FAQ

What is Neurogene stock price today?▼
The current price of UU8.STU is €17.2 EUR — it has decreased by -1.15% in the past 24 hours. Watch Neurogene stock price performance more closely on the chart.
What is Neurogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neurogene stocks are traded under the ticker UU8.STU.
Is Neurogene stock price growing?▼
UU8.STU stock has fallen by -3.91% compared to the previous week, the month change is a -9.71% fall, over the last year Neurogene has showed a +118.83% increase.
When is the next Neurogene earnings date?▼
Neurogene is going to release the next earnings report on May 08, 2026.
How many employees does Neurogene have?▼
As of April 12, 2026, the company has 107 employees.
In which sector is Neurogene located?▼
Neurogene operates in the Health & Wellness sector.
When did Neurogene complete a stock split?▼
Neurogene has not had any recent stock splits.
Where is Neurogene headquartered?▼
Neurogene is headquartered in New York, United States.